全文获取类型
收费全文 | 32658篇 |
免费 | 16255篇 |
国内免费 | 8篇 |
出版年
2022年 | 129篇 |
2021年 | 475篇 |
2020年 | 2231篇 |
2019年 | 3768篇 |
2018年 | 3899篇 |
2017年 | 4168篇 |
2016年 | 4198篇 |
2015年 | 4185篇 |
2014年 | 3809篇 |
2013年 | 4357篇 |
2012年 | 2051篇 |
2011年 | 1792篇 |
2010年 | 3197篇 |
2009年 | 1967篇 |
2008年 | 952篇 |
2007年 | 546篇 |
2006年 | 534篇 |
2005年 | 591篇 |
2004年 | 559篇 |
2003年 | 568篇 |
2002年 | 547篇 |
2001年 | 356篇 |
2000年 | 272篇 |
1999年 | 218篇 |
1998年 | 103篇 |
1997年 | 70篇 |
1996年 | 85篇 |
1995年 | 76篇 |
1994年 | 69篇 |
1993年 | 67篇 |
1992年 | 81篇 |
1991年 | 76篇 |
1990年 | 75篇 |
1989年 | 84篇 |
1988年 | 70篇 |
1987年 | 80篇 |
1986年 | 67篇 |
1985年 | 78篇 |
1984年 | 83篇 |
1983年 | 94篇 |
1982年 | 99篇 |
1981年 | 96篇 |
1980年 | 88篇 |
1979年 | 64篇 |
1978年 | 74篇 |
1977年 | 83篇 |
1976年 | 79篇 |
1975年 | 59篇 |
1974年 | 62篇 |
1973年 | 64篇 |
排序方式: 共有10000条查询结果,搜索用时 656 毫秒
81.
82.
83.
Banta Arthur M. 《Molecular & general genetics : MGG》1922,29(1):141
84.
Arthur E. Barker 《BMJ (Clinical research ed.)》1911,1(2631):1302-1304
85.
86.
87.
Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer 总被引:2,自引:0,他引:2
R H Wiltrout M R Boyd T C Back R R Salup J A Arthur R L Hornung 《Journal of immunology (Baltimore, Md. : 1950)》1988,140(9):3261-3265
The investigational drug flavone-8-acetic acid (FAA) potently augments NK activity in the spleen, liver, lungs, and peritoneum in a dose-dependent manner after i.v. or i.p. administration. Augmented NK activity peaks by 24 h after FAA injection and returns to normal after 6 days. Combined treatment of established murine renal cancer with FAA and rIL-2 results in up to 80% long term survival whereas FAA or rIL-2 alone were unable to induce any long term survivors. The optimal dose of rIL-2 required for use with FAA was in the range of 10,000 to 30,000 U/day. Further studies demonstrated that the regimen of FAA plus rIL-2 administration that was effective in treating established murine renal cancer also induced a more potent augmentation of NK activity than did either FAA or rIL-2 alone. Subsequent studies revealed that the therapeutic effectiveness of FAA plus rIL-2 was significantly reduced when tumor-bearing mice were treated with anti-asialo GM1 serum. These results are consistent with a role for augmented NK activity in the therapeutic effects of FAA plus rIL-2 murine renal cancer. In addition, these studies demonstrate that FAA and rIL-2 is a useful approach for cancer treatment in that subtoxic doses of rIL-2 can be used and significant anti-tumor efficacy occurs even without accompanying adoptive immunotherapy. 相似文献
88.
89.
90.
Johnathan L Meaders Erica F Geers Belen Fernandez‐Garcia Marvin E Tanenbaum 《The EMBO journal》2012,31(21):4179-4190
The microtubule motor protein kinesin‐5 (Eg5) provides an outward force on centrosomes, which drives bipolar spindle assembly. Acute inhibition of Eg5 blocks centrosome separation and causes mitotic arrest in human cells, making Eg5 an attractive target for anti‐cancer therapy. Using in vitro directed evolution, we show that human cells treated with Eg5 inhibitors can rapidly acquire the ability to divide in the complete absence of Eg5 activity. We have used these Eg5‐independent cells to study alternative mechanisms of centrosome separation. We uncovered a pathway involving nuclear envelope (NE)‐associated dynein that drives centrosome separation in prophase. This NE‐dynein pathway is essential for bipolar spindle assembly in the absence of Eg5, but also functions in the presence of full Eg5 activity, where it pulls individual centrosomes along the NE and acts in concert with Eg5‐dependent outward pushing forces to coordinate prophase centrosome separation. Together, these results reveal how the forces are produced to drive prophase centrosome separation and identify a novel mechanism of resistance to kinesin‐5 inhibitors. 相似文献